FDA seizes Enerzal stock from FDC depots in Maharashtra over misbranding probe
FDC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.3 pts less than Nifty Microcap 250 and 5.4 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
FDC told the exchange that FDA Maharashtra officials visited its depots at Chhatrapati Sambhaji Nagar and Nagpur on June 3, 2026, and seized stock of its product Enerzal, picking up samples for testing. The probe relates to alleged misbranding. FDC says there is no material financial impact, operations continue as usual, and the final examination order is awaited. The company will take legal recourse.
Minor for now with no material financial impact flagged, but final FDA order on Enerzal misbranding probe could affect product sales.